- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
NANOIDENT AG strengthens its capital and management base for further growth
NANOIDENT AG appointed the Austrian entrepreneur
Dr. Ulrich Stepski to its Advisory Board. Simultaneously, the Stepski private foundation
acquired a substantial share in NANOIDENT AG through a private equity placement.
NANOIDENT’s CEO Klaus Schroeter stated, “Dr. Stepski’s long standing management experience, his extensive international contacts in industry and the inflow of new growth capital create ideal conditions for NANOIDENT to further expand its position as the worldwide technological and market leader in the field of organic photonic sensors.” Dr. Ulrich Stepski emphasized, “NANOIDENT managed, at an early stage, to obtain a position offering good prospects in one of the most exciting future and growth markets with its globally unique products and top-class employee and management team, and thus providing optimum opportunities for above-average successful involvement.” In more than 20 years on the Board, Dr. Ulrich Stepski had shaped the successful development of Nettingsdorfer Papierfabrik, making it a global player in the paper industry.
Leading role in the field of organic sensors
NANOIDENT AG is the world’s first company specializing in the development and production of opto-electronics sensors based on organic semiconductors. Market experts estimate that today’s market volume of photodetectors equals approximately $10 billion US. In the next ten years, the market volume will triple as the new organic sensors, with their unique material properties and cost advantages, will open up entirely new markets, such as in the industrial, life science and security fields. At the “Plastic Electronics Congress & Showcase” in Frankfurt/Main, on 4./5. October 2005, NANOIDENT has presented the first high-resolution organic semiconductor-based photodetector for high-volume applications, which is a significant milestone for the commercialization of organic semiconductors.
NANOIDENT’s photodetector sets new global standards with 256 pixels, 250 dpi resolution and 50 x 50 ěm pixel size. For the realization of the world’s first high-resolution organic semiconductor-based photodetector, NANOIDENT has been awarded with the Upper Austrian Innovation Award 2005.
About NANOIDENT AG:
NANOIDENT is the leading nanotechnology company in the area of organic photonic sensors. The company develops and produces photonic sensors based on organic semiconductors for market segments with high growth potential, such as security technology and life science technology. NANOIDENT has succeeded in winning the world’s leading scientists and experts in organic photo physics as shareholders, collaborators and consultants, building unique know-how concerning nanotechnology-based organic semiconductors and production processes. NANOIDENT’s integration in international networks of expertise of the global leading research centers ensures access to latest research results in the area of organic semiconductor technology. In the context of technology partnerships with innovative industrial firms NANOIDENT develops trendsetting sensor solutions for high-volume market segments.
For more information, please click here
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Leading Advanced Materials Manufacturer Pixelligent Closes $10.4 Million in Funding: Capital Will Boost Capacity for North American Manufacturing, Drive Asian Expansion, and Continue Innovation in Solid State Lighting and OLED Display Applications August 16th, 2016
Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016 August 16th, 2016
Meteorite impact on a nano scale August 29th, 2016
Designing ultrasound tools with Lego-like proteins August 29th, 2016
50 years after the release of the film 'Fantastic Voyage,' science upstages fiction: Science upstages fiction with nanorobotic agents designed to travel in the human body to treat cancer August 25th, 2016
University of Puerto Rico and NASA back in the news – XEI reports August 23rd, 2016